FLT1 and cardiovascular disorder: This review focuses on a novel concept wherein the development of CKD-associated cardiovascular diseases is associated with noninfectious inflammation mediated by the signaling pathway of placental growth factor (PlGF) and its receptor, fms-like tyrosine kinase-1 (Flt-1).